Oxeia Biopharmaceuticals CEO, Dr. Michael Wyand, is participating in One Nucleus BioWednesday Webinar on concussions on Wednesday, July 14, 2021 from 11:00 am to noon Eastern Daylight Time: Prevention vs. Cure – If you can’t remove all risk can you at least treat the outcome? Panelists will discuss current R&D for concussion treatment, new technologies for diagnosing and monitoring concussions and the case for investing in new drugs to treat concussions.